BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18637311)

  • 1. A contrast-enhanced ultrasound study of benign and malignant breast tissue.
    Barnard S; Leen E; Cooke T; Angerson W
    S Afr Med J; 2008 May; 98(5):386-91. PubMed ID: 18637311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-enhanced ultrasound is helpful in the differentiation of malignant and benign breast lesions.
    Zhao H; Xu R; Ouyang Q; Chen L; Dong B; Huihua Y
    Eur J Radiol; 2010 Feb; 73(2):288-93. PubMed ID: 19559551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation between benign and malignant breast tumors using kinetic features of real-time harmonic contrast-enhanced ultrasound.
    Saracco A; Szabó BK; Aspelin P; Leifland K; Wilczek B; Celebioglu F; Axelsson R
    Acta Radiol; 2012 May; 53(4):382-8. PubMed ID: 22434928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can different regions of interest influence the diagnosis of benign and malignant breast lesions using quantitative parameters of contrast-enhanced sonography?
    Li J; Guo L; Yin L; Fang H; Ye W; Zhao B; Liu Y; Xu T
    Eur J Radiol; 2018 Nov; 108():1-6. PubMed ID: 30396640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced ultrasonography in diagnosis of benign and malignant breast lesions.
    Wang XY; Kang LK; Lan CY
    Eur J Gynaecol Oncol; 2014; 35(4):415-20. PubMed ID: 25118483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative, quantitative and combination score systems in differential diagnosis of breast lesions by contrast-enhanced ultrasound.
    Wang Y; Fan W; Zhao S; Zhang K; Zhang L; Zhang P; Ma R
    Eur J Radiol; 2016 Jan; 85(1):48-54. PubMed ID: 26724648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of dynamic contrast-enhanced ultrasound (CEUS) in non-cystic breast lesions using external perfusion software.
    Jung EM; Jung F; Stroszczynski C; Wiesinger I
    Sci Rep; 2021 Sep; 11(1):17677. PubMed ID: 34480040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective evaluation of contrast-enhanced ultrasound of breast BI-RADS 3-5 lesions.
    Janu E; Krikavova L; Little J; Dvorak K; Brancikova D; Jandakova E; Pavlik T; Kovalcikova P; Kazda T; Valek V
    BMC Med Imaging; 2020 Jun; 20(1):66. PubMed ID: 32552678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fast 3D Near-infrared breast imaging using indocyanine green for detection and characterization of breast lesions.
    Schneider P; Piper S; Schmitz CH; Schreiter NF; Volkwein N; Lüdemann L; Malzahn U; Poellinger A
    Rofo; 2011 Oct; 183(10):956-63. PubMed ID: 21972043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of breast lesions by contrast enhanced ultrasound: qualitative and quantitative analysis.
    Wan C; Du J; Fang H; Li F; Wang L
    Eur J Radiol; 2012 Apr; 81(4):e444-50. PubMed ID: 21612882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical significance of real-time contrast-enhanced ultrasonography in the differential diagnosis of breast tumor.
    Wenhua D; Lijia L; Hui W; Wei Y; Li T
    Cell Biochem Biophys; 2012 Jun; 63(2):117-20. PubMed ID: 22373958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can contrast-enhanced sonography distinguish benign from malignant breast masses?
    Sorelli PG; Cosgrove DO; Svensson WE; Zaman N; Satchithananda K; Barrett NK; Lim AK
    J Clin Ultrasound; 2010 May; 38(4):177-81. PubMed ID: 20146214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perfusion curve f (t) analysis of breast cancer by contrast-enhanced ultrasonography.
    Guo L; Liu ZG; Han PH; Yuan Q; He Y; Li J
    Acta Radiol; 2012 Nov; 53(9):981-6. PubMed ID: 22969089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of breast lesions with contrast-enhanced ultrasound using the microvascular imaging technique: initial observations.
    Liu H; Jiang YX; Liu JB; Zhu QL; Sun Q
    Breast; 2008 Oct; 17(5):532-9. PubMed ID: 18534851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-enhanced ultrasonography of peripheral soft-tissue tumors: Feasibility study and preliminary results.
    Gay F; Pierucci F; Zimmerman V; Lecocq-Teixeira S; Teixeira P; Baumann C; Blum A
    Diagn Interv Imaging; 2012 Jan; 93(1):37-46. PubMed ID: 22277709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of transducers with different frequencies in breast contrast-enhanced ultrasound (CEUS) using SonoVue as contrast agent.
    Wang YM; Fan W; Zhang K; Zhang L; Tan Z; Ma R
    Br J Radiol; 2016 Jul; 89(1063):20151050. PubMed ID: 27143439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benign and malignant breast lesions: efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging.
    Ricci P; Cantisani V; Ballesio L; Pagliara E; Sallusti E; Drudi FM; Trippa F; Calascibetta F; Erturk SM; Modesti M; Passariello R
    Ultraschall Med; 2007 Feb; 28(1):57-62. PubMed ID: 17304413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of diagnostic performance of unenhanced vs SonoVue - enhanced ultrasonography in focal liver lesions characterization. The experience of three Italian centers.
    Quaia E; Stacul F; Gaiani S; Ricci P; Passariello R; Curzio D; Pozzi Mucelli R
    Radiol Med; 2004; 108(1-2):71-81. PubMed ID: 15269691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of ultrasound in the evaluation of palpable breast tumours: a prospective study of 400 cases.
    Perre CI; Koot VC; de Hooge P; Leguit P
    Eur J Surg Oncol; 1994 Dec; 20(6):637-40. PubMed ID: 7995413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
    Hohmann J; Skrok J; Puls R; Albrecht T
    Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.